Home / Asia Pacific / Samsung Bioepis seeks Europe approval for its Humira copy

Samsung Bioepis seeks Europe approval for its Humira copy

Biosimilars maker Samsung Bioepis, part of South Korea’s top family-run conglomerate Samsung Group , said on Monday it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc’s rheumatoid arthritis drug Humira.
Source: Asia Pacific

About hmapj

Check Also

China denies its bomber aircraft on high state of alert amid North Korea tensions

China’s Defence Ministry on Friday denied reports that its bomber aircraft were on a heightened …

Leave a Reply

Your email address will not be published. Required fields are marked *